SCHEMBL21883761

SCHEMBL21883761

C#Cc1cncc(C(C)CCC)c1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19880573 0.87 TSHR (0.32) —
SCHEMBL21883550 0.86 KDM4E (0.32) —
SCHEMBL19769058 0.79 P2RX3 (0.37) —
SCHEMBL22096864 0.72 ALDH1A1 (0.33) —
SCHEMBL19779693 0.72 ALDH1A1 (0.33) —
SCHEMBL21565411 0.70 PTPN1 (0.37) —
SCHEMBL19779702 0.69 CYP11B1 (0.32) —
SCHEMBL19778439 0.68 CYP2E1 (0.38) —
SCHEMBL18927455 0.67 ADRA2A (0.30) —
SCHEMBL20621645 0.65 AOC1 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10597377-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2020-03-24 — — US disclosed
Send feedback